SEMA3E and systemic sclerosis: It is worth noting that previous studies from our group reported altered levels of circulating sNRP1 and Sema3E also in subjects who were suffering from RP, with decreased sNRP1 in patients with a very early diagnosis of SSc (VEDOSS) and elevated Sema3E in subjects with primary RP [20,21].